Sign Out
Citicoline is effective in the following conditions: acute period of ischemic stroke; rehabilitation period after ischemic and hemorrhagic stroke; head injury, acute and rehabilitation period; cognitive abnormalities at degenerate and vascular diseases of brain.
Special indications: Mannitol or corticosteroids should be prescribed to decrease the intracranial pressure in brain damages.
Citicoline dose should not exceed 500 mg for single dose administration in intracranial hemorrhage (100-200 mg for 2-3 times daily).
Continue with Google